Log In
BCIQ
Print this Print this
 

Alveodex (Factor VIIa)

  Manage Alerts
Collapse Summary General Information
Company CMC Biologics A/S
DescriptionHuman Factor VIIa (rhFVIIa)
Molecular Target Factor VIIa
Mechanism of ActionFactor VIIa inhibitor
Therapeutic ModalityBiologic
Latest Stage of DevelopmentDiscovery
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat diffuse alveolar hemorrhage (DAH)
Regulatory Designation
PartnerSavara Pharmaceuticals

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/18/2016

Undisclosed

Undisclosed

Undisclosed

01/30/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today